Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Search results for

There are 42,989 results that match your search.42,989 results
  • Myriad - Australia edition
    Australia’s High Court held oral arguments today on the issue of whether an isolated gene is patentable
    June 16 2015
  • upc20web20icon20150.jpg
    In-house patent counsel: we want your views on the UPC!
    The past few months have seen important developments regarding the fees, procedures and rules for the new Unitary Patent and UPC system in Europe. In the light of these, we are inviting in-house counsel to complete a short survey and to win an iPad mini 3
    June 17 2015
  • Andy Booth Dyson
    IP in Asia (1) – takeaways from London forum
    Specialist IP courts, underused IP rights and the benefits of alternative dispute resolution across the region were some of the issues discussed at Managing IP’s IP in Asia events in London last week
    June 15 2015
  • Vringo receives six-month delisting reprieve
    The patent assertion entity announced today that it has received a six-month grace period to raise its share price to the $1 minimum
    June 18 2015
  • OHIM study table 1
    IP-owning companies perform better – OHIM study
    Businesses that own IP rights generate more revenue per employee, have more employees and pay higher salaries than those that do not, according to a new report by the Observatory on Infringements of Intellectual Property Rights
    June 18 2015
  • kyle20bass20150.jpg
    PTAB allows Celgene to file for sanctions against Coalition for Affordable Drugs
    The Patent Trial and Appeal Board has authorised Celgene to file motions for sanctions in response to four inter partes review petitions filed by the Coalition for Affordable Drugs, the entity Kyle Bass and Erich Spangenberg are using to challenge pharmaceutical patents
    June 18 2015
  • Bio/pharma IPRs by the numbers
    Figures discussed at the BIO International Convention reveal that bio/pharma IPRs at the Patent Trial and Appeal Board have a lower institution rate and lower claim-cancellation rate than for all IPRs
    June 17 2015
  • CIPA AI panel
    Could a computer do your job?
    Artificial intelligence is developing so fast that a patent will be filed, and granted, without human intervention within 25 years. That was the proposition at a debate organised by the Chartered Institute of Patent Attorneys in London
    November 03 2015
  • bob Surrette
    View our webinar on obviousness in US district courts and PTAB
    View a replay of our “Effective obviousness arguments in district courts and PTAB” webinar, which took place on November 4 and featured McAndrews Held & Malloy president Robert Surrette and Stryker intellectual property counsel Mary Elizabeth Mauro
    November 03 2015
  • DeFranco-Denise
    Associations suggest patent eligibility guidance changes to USPTO
    The deadline for comments on the USPTO’s July update to its patent eligibility guidance has passed, with 29 submissions. This included the American Intellectual Property Law Association making seven broad recommendations
    November 03 2015
Previous
183
of
4299
Next